Irvine's Cardiac Science Inc. has completed private placements totaling $38 million.
Lead contributors for the deal were Houston's AIM Investment Funds and New York-based Special Situations Private Equity Fund.
Medical device maker Cardiac Science manufactures the Powerheart External Cardioverter Defibrillator, which constant...
Lead contributors for the deal were Houston's AIM Investment Funds and New York-based Special Situations Private Equity Fund.
Medical device maker Cardiac Science manufactures the Powerheart External Cardioverter Defibrillator, which constant...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In




